Log in to save to my catalogue

CRISPR-Cas9-Mediated Gene Therapy in Neurological Disorders

CRISPR-Cas9-Mediated Gene Therapy in Neurological Disorders

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_2601482401

CRISPR-Cas9-Mediated Gene Therapy in Neurological Disorders

About this item

Full title

CRISPR-Cas9-Mediated Gene Therapy in Neurological Disorders

Publisher

New York: Springer US

Journal title

Molecular neurobiology, 2022-02, Vol.59 (2), p.968-982

Language

English

Formats

Publication information

Publisher

New York: Springer US

More information

Scope and Contents

Contents

Neurological disorders are primarily diseases with sophisticated etiology that are always refractory and recrudescent. The major obstruction to effective therapies for neurological disorders is the poor understanding of their pathogenic mechanisms. CRISPR-Cas9 technology, which allows precise and effective gene editing in almost any cell type and o...

Alternative Titles

Full title

CRISPR-Cas9-Mediated Gene Therapy in Neurological Disorders

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_proquest_miscellaneous_2601482401

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_2601482401

Other Identifiers

ISSN

0893-7648

E-ISSN

1559-1182

DOI

10.1007/s12035-021-02638-w

How to access this item